Loading clinical trials...
Loading clinical trials...
Ramucirumab Plus Irinotecan in Patients With Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma
Conditions
Interventions
Irinotecan
Ramucirumab
+2 more
Locations
4
United States
University of Miami - Sylvester Comprehensive Cancer Center
Miami, Florida, United States
H. Lee Moffitt Cancer Center and Research Institute, Inc.
Tampa, Florida, United States
Washington University School of Medicine
St Louis, Missouri, United States
UT Southwestern Medical Center
Dallas, Texas, United States
Start Date
November 1, 2017
Primary Completion Date
April 14, 2023
Completion Date
April 14, 2023
Last Updated
June 25, 2024
NCT06901531
NCT07282912
NCT05677490
NCT07001748
NCT05753306
NCT04290806
Lead Sponsor
Washington University School of Medicine
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions